Dapagliflozin: an effective adjunctive treatment in type 1 diabetes

INTRODUCTION: Many people with type 1 diabetes (T1DM) continue to run high HbA1c levels with an associated elevated risk of cardiovascular events and increased mortality. We describe here how adjunctive prescription of an SGLT2 inhibitor has improved the glycaemic control of several people with T1DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadegarfar, Ghasem, Livingston, Mark, Cortes, Gabriela, Alshames, Ramadan, Leivesley, Kate, Metters, Ann, Horne, Linda, Steele, Tom, Heald, Adrian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189611/
https://www.ncbi.nlm.nih.gov/pubmed/34124604
http://dx.doi.org/10.1097/XCE.0000000000000248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189611/
https://www.ncbi.nlm.nih.gov/pubmed/34124604
http://dx.doi.org/10.1097/XCE.0000000000000248

Ejemplares similares